DrugPatentWatch Database Preview
Drugs in Development Information for Caprylic acid
» See Plans and Pricing
What is the drug development status for Caprylic acid?
Caprylic acid is an investigational drug.
There have been 5 clinical trials for Caprylic acid.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2013.
The most common disease conditions in clinical trials are Peripheral Nervous System Diseases, Diabetic Neuropathies, and Tremor. The leading clinical trial sponsors are Accera, Inc., Celerion, and University of British Columbia.
There are three US patents protecting this investigational drug and thirty-eight international patents.
Summary for Caprylic acid
US Patents | 3,059 |
International Patents | 38,873 |
US Patent Applications | 3,525 |
WIPO Patent Applications | 2,486 |
Japanese Patent Applications | 11 |
Clinical Trial Progress | Phase 1 (2013-07-01) |
Vendors | 72 |
Recent Clinical Trials for Caprylic acid
Title | Sponsor | Phase |
---|---|---|
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy | University of British Columbia | Phase 1/Phase 2 |
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production | Celerion | Phase 1 |
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production | Accera, Inc. | Phase 1 |
Clinical Trial Summary for Caprylic acid
Top disease conditions for Caprylic acid
Top clinical trial sponsors for Caprylic acid
US Patents for Caprylic acid
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Caprylic acid | Start Trial | Glycolurils having functional groups and use thereof | SHIKOKU CHEMICALS CORPORATION (Kagawa, JP) | Start Trial |
Caprylic acid | Start Trial | 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors | Janssen Pharmaceutica NV (Beerse, BE) | Start Trial |
Caprylic acid | Start Trial | Water temperature as a means of controlling kinetics of onsite generated peracids | Ecolab USA Inc. (Saint Paul, MN) | Start Trial |
Caprylic acid | Start Trial | Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes | APOGLYX AB (Lund, SE) | Start Trial |
Caprylic acid | Start Trial | Isocyanate derived organosilanes | THE CHEMOURS COMPANY FC, LLC (Wilmington, DE) | Start Trial |
Caprylic acid | Start Trial | Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer | Cocrystal Pharma, Inc. (Tucker, GA) Emory University (Atlanta, GA) | Start Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Caprylic acid
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Caprylic acid | China | CN105745213 | 2033-11-25 | Start Trial |
Caprylic acid | China | CN108164534 | 2033-11-25 | Start Trial |
Caprylic acid | China | CN108276412 | 2033-11-25 | Start Trial |
Caprylic acid | European Patent Office | EP3075735 | 2033-11-25 | Start Trial |
Caprylic acid | European Patent Office | EP3369735 | 2033-11-25 | Start Trial |
Caprylic acid | Japan | JP2015120897 | 2033-11-25 | Start Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |